Skip to main content

Table 1 EVL/MIR342 methylation frequency in NHL primary samples

From: Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy

Disease subtype Sample size Methylation (%)
B-NHLs 99 68 (68.69%)
 Diffuse large B cell lymphoma (DLBCL) 56 42 (75.00%)
 Follicular lymphoma (FL) 6 4 (66.67%)
 Mantle cell lymphoma (MCL) 17 4 (23.53%)
 Burkitt’s lymphoma (BL) 5 4 (80.00%)
 Mucosa-associated lymphoid tissue lymphoma (MALT) 4 4 (100.0%)
 Marginal zone B cell lymphoma (MZBCL) 3 2 (66.67%)
 Small lymphocytic lymphoma (SLL) 7 7 (100.00%)
 Waldenstrom’s macroglobulinemia (WM) 1 1 (100.00%)
T-NHLs 33 8 (24.24%)
 Peripheral T cell lymphoma (PTCL) 20 5 (25.00%)
 Angioimmunoblastic T cell lymphoma (AITL) 13 3 (23.08%)